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EDITORIAL REVIEW
The glomerular mesangium
The one million or so glomeruli present in each of
our kidneys are remarkably constructed. It is here
that the ultrafiltrate of plasma is formed to be eco-
nomically reabsorbed by tubules, leaving behind
substances of no further use to the body. It is also
here that the movement of macromolecules across
the peripheral glomerular capillary is impeded by
the basement membrane and by fixed polyanions in
the capillary wall. Also within the glomerulus is an
anatomically distinct region—the mesangium. The
traffic of macromolecules through this zone appears
to be significantly influenced by changes in the pe-
ripheral glomerular capillary as well as by other ex-
perimental manipulations. In human glomerulone-
phritis, immune deposits are found here, often ex-
clusively. Morphologic abnormalities have ranged
from the mesangial matrix expansion and the char-
acteristic intercapillary nodule formation of diabetic
nephropathy to the prominent proliferation of mem-
branoproliferative glomerulonephritis and the seg-
mental changes seen in a host of different diseases.
Anato/nic relations/zips
Although the term mesangium was first used over
40 years ago to denote connective tissue cells aris-
ing in the stalk and extending to the inner aspect of
the glomerular capillary [I], a number of years
elapsed before there was general agreement that
such a region within the glomerulus did in fact exist
[2-6]. The precise relationship of the mesangium
(mesangial cells and matrix) to other parts of the
glomerulus was defined after the application of elec-
tron microscopic techniques to the study of the kid-
ney [7—9]. The mesangial cell has been described as
being centrolobular and deep to denote its unique
location, which is distinct from regions occupied by
endothelial and epithelial cells. In this locus the
mesangium is bounded by the endothelium, which
separates it from the capillary lumen, and the mes-
angial reflection of the glomerular basement mem-
brane (GBM) and hence forms part of the glomeru-
lar capillary wall (Fig. I). In the strictest sense,
therefore, the mesangium has an intracapillary and
not intercapillary location. The cells have branching
cytoplasmic processes and contain a number of or-
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ganelles, including course microfilaments, which re-
semble myosin filaments, suggesting that these cells
may be modified smooth muscle cells [11, 12]. Al-
though myosin has been demonstrated in the mes-
angium with immunofluorescent microscopy, its lo-
calization in filaments with ultrastructural tech-
niques has not been documented [13-15] (Fig. 2).
An intercellular substance, the mesangial matrix, is
present between the cells, and although morpholog-
ically similar to the GBM, its complete biochemical
and antigenic structure is unknown. Of great signifi-
cance is the relationship of the mesangium to the
juxtaglomerular (JG) apparatus. In the stalk region,
the mesangium lies in close proximity to the lacis
cells, which are contiguous with the epithelioid gran-
ulated cells of the afferent arteriole and the macula
densa [10, 16-20]. Gap junctions also have been re-
ported in mesangial and lacis cells of the rat, suggest-
ing that these cells are coupled and may act as a func-
tional syncitium [21]. This intimate structural rela-
tionship of the mesangium to the JG zone is impor-
tant for at least two reasons: (I)the mesangium may
play a role in the regulation of glomerular blood
flow, although there is no direct evidence at the mo-
ment to support this concept; and (2) as described
later, this region may provide a route for the egress
of macromolecules from the peripheral mesangium.
The intracapillary position of the mesangium has
made it relatively inaccessible to study either in the
intact animal or in vitro. Although attempts have
been made to isolate mesangial cells directly from
glomeruli, these studies have been unsuccessful be-
cause of the cloistered centrolobular location of these
cells in the glomerulus. Replicating cells have been
isolated from in vitro cultures of glomeruli, but di-
rect comparison with isolated native mesangial cells
has not been possible [22-28]. Although the mes-
angial matrix has a morphologic appearance similar
to that of GBM, and in disease states has been
Received for publication February 6, 1979
and in revised form July II, 1979
0085-2538/80/0017—0141 $02.80
© 1980 by the International Society of Nephrology
142 Michael ci a!
Fig. 1. Diagra,n of a rat mesangial region surrounded by capillaries. The central layer (CL) of the basement membrane invests the
capillaries like a sheet and also passes over the mesangial region. The capillary boundary of the mesangium is formed by the axial
portions of endothelial cells (En). Mesangial cells (M) are partially surrounded by mesangial matrix (Ma), in which bundles of collagen
(Co) can sometimes be found. Fenestrations (F) of the endothelium allow passage of particles and plasma into intercapillary and inter-
cellular channels (IC). rhe thicknesses of the outer layer (OL) and inner layer (IL) (lamina rara interna and externa) of the basement
membrane have been drawn thicker than they are to show their relationships to the adjacent cells. The central layer (lamina densa) is thin
in the rabbit, mouse, and rat (as shown here) but much thicker in the monkey and human beings. Epithelial cell bodies (Ep) extend
primary processes, which branch to form the foot processes. The capillary diameter is usually somewhat greater than the diameter of a
red blood cell (RBC). (Reprinted with permission of J Ultrasir Res [81 and American Physiological Society 1101)
referred to as basement membrane-like material,"
there is no evidence that these two structures are
the same. Indeed, antibody eluted from the GBM of
patients with anti-GBM nephritis reacts exclusively
with the endothelial aspect of the GBM and not with
the mesangial matrix 1129]. Electron microscopic
studies with tissue immersed in 5 M quanidine prior
to fixation have demonstrated, however, two classes
of GBM: an electron-opaque basal lamina that does
not encircle the capillary (epithelial basal lamina),
and an electron-lucent basal lamina that extends
from the mesangium peripherally and surrounds the
capillary lumen as an attentuated structure (mesan-
gial and endothelial basal lamina) [30]. This continu-
ity between the endothelial and mesangial basement
membranes may provide a pathway for the move-
ment of certain materials from the peripheral capil-
lary loop to the mesangium. Immunohistochemical
studies have demonstrated that certain collagen and
glycoprotein antigens are present both in the mes-
angium and in the subendothelial region of the GBM
(see below, Mesangial antigens).
Motphologic probes
The mesangial interstitial space is unique in
that entry of a substance does not require passage
through a capillary basement membrane. It has
been possible to demonstrate sequestration of a
number of different macromolecules within the
mesangium of experimental animals, including (I)
inorganic suspensions—thorium dioxide suspension
(thorotrast), colloidal gold, colloidal carbon; (2)
polysaccharides—dextran, iron dextran, polyvinyl
alcohol polymers; (3) proteins—peroxidase, cata-
lase, and ferritin: and (4) aggregated proteins and
immune complexes (Table I).
Following their administration to rats, thorium




Fig. 2. A normal glomerulus demonstrating actomyosin within
the mesangium. (Magnification, x683) (Modified from Ref. 15)
gial channels and intercellular spaces between the
endothelium and the mesangial cell within minutes
of injection [8, 9]. In addition, the tracer is present
within membrane-limited vesicles and vacuoles in
the cytoplasm of mesangial cells. These particles
are thought to enter the mesangium through the
endothelial fenestra at the edge of the mesangial
zone, although entry into the lamina rara interna at
the periphery with migration into the mesangium
cannot be excluded. In Farquhar's [9, 45] classical
studies with ferritin, an iron-containing protein,
penetration through the endothelial fenestra and in-
Table 1. Substances taken up by the mesangium following their
administration to animals
Probe
Mol wt (radius or )a
daltons (A or s)
Inorganic particles
Colloidal carbon [3 1-34]
Thorium dioxide [8, 9]
Colloidal gold [9]
(200 to 300 A)
(50 to 200 A)




200,000 (37 x 220 A)
125,000 (78 A)
250,000 (100 A)










Aggregated protein and complexes
Aggregated globin [47] (250 to 1000 A)
Aggregated human IgG [48-50] (>7s)
Aggregated human albumin [48. 511 —
Antigen-antibody complexes [52—54] 473,000 (Ils): >473,000
(>lls)
Adapted in part from Refs. 55 and 56.
tercellular spaces between the endothelium and
mesangial cells could be demonstrated within min-
utes following injection. Active phagocytosis be-
came evident within several minutes, reaching a
peak within several hours, but within a period of 2
to 10 days, the mesangial zone was "cleared" of the
ferritin. In nephrotic animals, the femtin deposits at
any one time period were more massive than they
were in contrors, a finding of importance when
viewed in the light of subsequent kinetic studies
with aggregated proteins.
When polysaccharide and protein tracers of vary-
ing molecular weights and sizes are administered to
rats, a similar distribution of the molecules is ob-
served between and within mesangial cells. Ultra-
structural studies in the rat demonstrate that carbon
particles enter the mesangial channels and are en-
gulfed by cells within the mesangium in a manner
similar to that observed for thorotrast [32]. At vari-
ance with studies carried out with other macromo-
lecular tracers are the observations that the amount
of carbon in the mesangium was maximal at 32
hours, with continued presence within the stalk re-
gion for weeks. A similar persistence has been ob-
served following the administration of ferritin-pro-
tein conjugates to rats [46].
Because of the presence of immune deposits in
the mesangium in human and experimental renal
diseases, a number of studies have been carried out
with aggregated proteins and preformed immune
complexes [47-54] (reviewed in [56]). Observations
derived from studies carried out in mice and rats
following administration of aggregated human IgG
(AH IgG) or albumin include the following: (1)
These macromolecules were demonstrated almost
exclusively within the mesangial region within 4
hours following administration to the animal, with a
gradual disappearance over the subsequent 24 to 72
hours. Avid uptake by cells of the systemic mono-
nuclear phagocytic system was also observed. (2)
The accumulation in the mesangium depended on
the amount administered to the animal, suggesting
that the blood level was an important determinant
[48, 50]. (3) Although AH IgG has been shown to
have biologic properties, decomplementing the ani-
mal with cobra venom factor had no effect on mes-
angial accumulation [50]. In addition, similar results
were obtained with a nonimmunoprotein, aggre-
gated albumin [48, 51]. (4) The size and type of the
macromolecule played an important role in view of
the striking mesangial localization of AH IgG
(>7s) compared with the negligible localization of
monomeric IgG (7s) [48, 49], or the rapid clearance
from the mesangium of AH IgG compared with the
persistence of carbon in this site [32]. (5) By elec-
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tron microscopy, aggregated proteins were ob-
served initially in the endothelial fenestra and the
interface between mesangial cells and endothelial
cells and in the channels present between mesangial
cells; minimal uptake of aggregated albumin by
mesangial cells was demonstrated [48, 51]. A simi-
lar intercellular distribution of antigen-antibody
complexes has been demonstrated by Haakenstad
and Mannik [53] and Striker, Mannik, and Tung
[57] with no detectable phagocytosis by mesangial
cells.
Kinetic studies of the mesangium
Most attempts to evaluate the mesangium have
involved immunofluorescent and ultrastructural
techniques. It has been possible, however, to study
the kinetics of mesangial uptake and disposal of
macromolecules by more quantitative techniques
[49, 50]. Following the administration of labeled
(1251) AH IgG, glomeruli are isolated from groups of
rats at varying time intervals thereafter, and the
concentration of AH IgG (microgram per milligram
of glomeruli) determined. These studies are predi-
cated on morphologic observations showing almost
exclusive localization within the mesangial zone of
the glomerulus within 4 hours. In a typical experi-
ment, a linear decrease in the concentration of gb-
merular aggregates is seen with time (Fig. 3). There
is an associated but much more precipitous drop in
the blood level, so that by 16 hours less than 2% of
the initial value is present, whereas the amount re-
maining in the glomerulus has decreased to approxi-
mately 40% of initial values. After an initial period
of rapid uptake, which in the normal animal is maxi-
mal within 4 hours occurring at a time when the
blood level is relatively high, there is loss of aggre-
gates from the mesangium as the blood level pro-
gressively decreases. Similar kinetics have been
demonstrated for ferritin by Takamiya et al [46].
This movement into and out of the mesangium may
be separated arbitrarily into afferent and efferent
limbs. Because efferent mechanisms probably come
into play shortly after uptake has occurred, a clear-
ly defined time line does not separate these two pro-
cesses. The initial 4-hour period likely represents,
however, the peak of the afferent limb, whereas
subsequent time periods reflect efferent mecha-
nisms. Any attempt to separate those two phases
into clear compartments is artificial because the up-
take and loss of material from the mesangium repre-
sents a continuum.
Affereni mesangial limb
Substances enter the mesangial zone by way of
the endothelium-mesangium interface and thence
migrate by means of mesangial channels and in
some instances are phagocytosed by mesangial and
monocytic cells. The factors modulating uptake are
probably numerous; several, however, have been
identified (Table 2):
(1) Blood level and characteristics of the macrornol-
ecule. (a) In studies of immune complex trapping by
the kidney, the blood level would appear to be a more
important determinant than are other variables such
as delivery rate, hydrostatic pressure, and ultrafil-
tration rate [58]. Similarly, the blood level of AH
IgG or immune complexes is an important determi-
nant of the amount taken up by the mesangium.
This is reflected by the relationship between the
amount of AH IgG or ferritin administered to rats
and mesangial accumulation [46, 48, 50] (Fig. 4).
When very low doses are administered, many or-
gans trap aggregates more avidly than the renal cor-
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Time after administration, hr
Fig. 3. Relationship between the concentration of AH IgG in
glomeruli of normal and aminonucleoside nephrotic rats and the
time interval after administration of AH IgG. The blood levels
were similar in both groups of animals. Each point on the ordi-
nate represents the concentration in glomeruli expressed as a
percentage of the control value at 4 hours, the time at which
aggregates were exclusively in the mesangium as demonstrated
by immunohistochemical techniques. Note the striking increase
in accumulation of AH IgG in aminonucleoside animals and the
similar negative slopes from 4 to 36 hours. (Modified from Ref.
49)
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a. Blood level of macromolecule-.—related to systemic mono-
nuclear phagocytic system
b. Characteristic of the macromolecule (size, type, digestibil-
ity, charge)
2. Characteristics of the glomerular capillary
3. Hemodynamic factorsa
Efferent limb
I. Phagocytosis by mesangial cells or infiltrating phagocytes
2. Transport via stalk to juxtaglomerular zone
3. Capillary regurgitatio&'




Relationship to blood flow, capillary pressure, and glomeru-
lar filtration is largely unknown.
bNot demonstrated
[59]. Because many of the tracers used to evaluate
mesangial function—ferritin, aggregated proteins,
antigen-antibody complexes—are also taken up by
the systemic mononuclear phagocytic system, it is
not surprising that the latter plays an important role
in modulating mesangial uptake. Indeed, in the
early studies of Benacerraf, McCluskey, and Patres
[31], glomerular uptake of carbon was observed only
alter relatively high doses that saturated the retic-
uloendothelial system. In experimental serum sick-
ness nephritis, the amount of antigen-antibody
complexes that become entrapped within the gb-
merulus represented a very small proportion of that
taken up by the mononuclear phagocytic system
[60]. Therefore, for any macromolecule, avid sys-
temic phagocytic uptake would lead to relatively
low blood levels and a decrease in the amount of
material found in the mesangium. Conversely, re-
duced phagocytic uptake would favor persistence of
relatively higher levels for longer periods of time
and consequently increased deposition within the
mesangial zone. Strong support for this viewpoint
was derived from studies by Haakenstad et al [52-.
54, 61], who demonstrated a relationship between
the glomerular localization of immune complexes
and the blood level in mice. Large (> I Is) latticed
complexes prepared with reduced and alkylated
antibody were removed less efficiently by the hepat-
ic mononuclear phagocytic system than were com-
plexes made with intact antibody, leading to per-
sistently higher blood levels of the former and in-
creased mesangial sequestration. In mice treated
with corticosteroids, the administration of pre-
formed antigen-antibody complexes or AN IgG re-
suited in increased deposition within the mesan-
gium—in part related to higher blood levels of the
macromolecule secondary to a generalized decrease
in vascular permeability [52], as well as changes in
nonhepatic (splenic) phagocytic uptake [62]. Whether
changes in glomerular hemodynamics induced by
corticosteroids play a role has not been determined.
The change in the distribution of immune deposits
from a peripheral capillary ioop to a mesangial pat-
tern observed by Germuth and Rodriquez [63] after
administration of cortisone to rabbits with serum
sickness may be related to the variables discussed
above as well as changes in the immunologic re-
sponse of the animal. Our recent studies in endo-
toxin-treated mice demonstrate a discordance be-
tween mesangial or cortical uptake and the circu-
lating level of administered AH IgG (Shvil et al, in
press). Although endotoxin induces a significant in-
S
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Dose of AH IgGmg/lOOgbocly wt
Fig. 4. Relationship between dose and glomerular con centra-
tions of AH IgG 8 hours following injection into nephritic and
control rats. The nephritic rats had received goat antirat GBM;
and the control rats, normal goat serum 48 hours prior to admin-
istration of AH lgG. Note the dose-response in each group of
animals and the significant increase in glomerular uptake in neph-
ritic rats. Each point represents pooled glomeruli from five rats.
(Data from Ref. 50)
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crease in uptake of aggregates by the mononuclear
phagocytic system and as a consequence causes a
reduction in the blood level, a concomitant de-
crease in mesangial uptake was not observed, and,
in fact, at early time periods increased uptake was
demonstrated. Thus, endotoxin influences mesan-
gial uptake by a mechanism(s) that is independent
of its effect on the blood level.
The concept that the mesangial uptake of macro-
molecules is inversely related to systemic mono-
nuclear phagocytic activity is in keeping with stud-
ies demonstrating increased mesangial deposition of
aggregated albumin in certain strains of mice with
relatively decreased clearances of carbon from the
blood [64], and by studies that propose but do not
prove that the viremia of lymphocytic choreomen-
ingitis leads to depressed phagocytic function,
which contributes to defective immune complex
clearance, and increased localization within gb-
meruli of nephritic animals [65].
(b) The morphologic studies cited above suggest
that the mesangial transport of macromolecules of
widely differing size and type is not an all or none
phenomenon and that plasma percolates through
the mesangium, likely under the control of hemo-
dynamic influences. That size is an important de-
terminant is suggested by studies demonstrating en-
hanced accumulation of aggregated proteins com-
pared with that of the nonaggregated monomeric
species [48, 49]. That differences other than size
may be responsible for these observations has not
been excluded. As discussed more completely be-
low, increased accumulation of different macromol-
ecules—carbon [33, 34], ferritin [45] and AH IgG
[49, 50]—is observed in experimental nephrotic
syndrome, a circumstance not seen with other
probes such as monomeric 7s IgG [49]. It is possible
that the movement of very large macromolecules
through the mesangial zone is impeded compared
with that of smaller molecules. The relative diges-
tibility of a macromolecule also may play an impor-
tant role in its clearance from the mesangium. For
example, the prolonged persistence of carbon [32,
34] and polyvinyl alcohol polymers [38-40] is prob-
ably a consequence of overloading of phagocytes
and the mesangium with indigestible residues.
There is evidence based on experimental studies
that the type of antigen-antibody complex may in-
fluence the site of localization vessels and glomeruli
[63, 66-68]. Poorly soluble complexes of inter-
mediate size localize within the mesangium. result-
ing in a relatively innocuous lesion, whereas smaller
more soluble complexes present in low concentra-
tions are deposited in the peripheral capillary loop.
Other studies have shown that immune complexes
either formed in vivo or administered passively,
which contain antibody of high avidity, affinity, and
valence, are taken up by the mesangium in contrast
to complexes containing antibody of relatively low
affinity and valence, which tend to localize within
the peripheral loop [69, 70]. Very little information
is available regarding this relationship in human gb-
merubonephritis. The occurrence of membranous
nephropathy in lupus erythematosus has been asso-
ciated with low titers of nonprecipitating DNA anti-
body and lower or undetectable levels of circulating
immune complexes, whereas in proliferative dis-
ease high levels of precipitating DNA antibody and
circulating immune complexes are present [71. 72].
Polyanionic radicals within the glomerular capil-
lary wall are known to play a major role in the filtra-
tion of macromolecules. With histochemical tech-
niques that are optimal for the staining of negatively
charged sialoproteins and which readily detect the
epithelial polyanion, no reactivity with the mesan-
gium could be demonstrated [73]. Recently, how-
ever, Kanwar and Farquhar [74, 75] have demon-
strated a lattice-like network of negatively charged
sites within the lamina rara externa, the lamina rara
interna, and the mesangial matrix, which morpho-
logically resemble proteoglycan and which contain
heparan sulfate.
(2) Characteristics of the glo,nerular capillary.
Essentially nothing is known about how the gb-
merular capillary itself modulates the afferent limb.
Are there selective interactions between macromol-
ecules and components of the mesangial matrix and
cells? Do receptors, protein-protein binding, and in-
trinsic electrostatic charge play a role in the uptake
of a specific macromolecule? What is the relation-
ship between the peripheral glomerular capillary
and the mesangium?
A striking increase in the mesangial accumulation
of aggregated proteins, carbon, and ferritin has
been demonstrated in two different forms of gb-
merular capillary injury —amnionucleoside neph-
rosis and anti-GBM nephritis [9, 33, 34, 49, 50]. Fol-
lowing the administration of AH IgG to the normal
rat, there is prompt gbomerular uptake followed by a
linear fall-off in concentration, which parallels that
observed in other organs such as the lung, liver, and
spleen. In both experimental models, there is an in-
crease in mesangial uptake to values tenfold higher
than that observed in controls [49, 50] (Figs. 3 and
4). The rate of disappearance between 4 and 36
hours is not different because the curves derived
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from normal and nephritic animals had similar nega-
tive slopes, suggesting that efferent mechanisms
were relatively unaffected. Depletion of terminal
complement components by cobra venom factor in
nephritic animals reduced the uptake of AH IgG,
although values were still significantly higher than
those of controls, findings which implicate com-
plement dependent and independent mechanisms.
This enhanced uptake did not depend on the ap-
pearance of protein in the urine in either model:
similar changes were observed after the administra-
tion of an amount of anti-GBM antibody that was
below the threshold to induce proteinuria or very
early after administration of aminonucleoside prior
to the appearance of proteinuria.
That these changes were related to alterations in
the kidney itself was demonstrated by induction of
unilateral renal disease by direct infusion of amino-
nucleoside or anti-GBM antibody into one renal ar-
tery [33, 34]. Increased mesangial uptake of macro-
molecules (carbon or AH IgG) was demonstrated
only in the perfused kidney, providing strong sup-
port for the contention that the changes were not
related to alterations in the systemic milieu but
rather to changes in the kidney itself (Fig. 5). These
studies are consistent with the early electron micro-
scopic observations of Farquhar et al [45] demon-
strating increased amounts of ferritin within mesan-
gial matrix and cells in nephrotic animals. In autolo-
gous immune complex nephritis, a change in the
pattern of immune deposits, from epimembranous
to mesangial, was demonstrated after administra-
tion of the aminonucleoside of puromycin, suggest-
ing that alteration in glomerular capillary per-
Fig. 5. A and B Glomeru/ifrom a rat 24 hours after administration of carbon. The glomerulus from a normal nonpersused kidney contains
small amounts of carbon (pane/A). Note the large amount of carbon in the mesangium (pane/B), which is from the centralateral kidney
perfused with anti-GBM antibody. C and D Glum eruli from a rat 12 hours after injection of AH JgG. Trace fluorescence is noted in the
mesangium of a nonperfused kidney stained for human IgG (panel C). Note the intense mesangial staining for AH IgG in the contralateral
kidney perfused with aminonucleoside 10 days previously (panel D). (Magnification of A,B,C, x450; of D. x330) (Reprinted with
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meability may affect the locus of immune complex
deposition in an ongoing autoimmune disease [76].
The cause of the change in the afferent mesangial
limb induced by aminonucleoside or anti-GBM anti-
body is unknown. It is possible that these findings
are related to the abbrogation of the negative charge
in the glomerular capillary epithelium in both exper-
imental models [73, 77]. In this regard, the observa-
tion in autologous immune complex disease of a de-
crease in mesangial uptake of carbon in conjunction
with the failure to detect a decrease in stainable gb-
merular polyanion early in the disease are at vari-
ance with the findings in the other two models [78,
79]. These data suggest that the two phenomenona,
electrostatic charge and mesangial traffic, may be
linked in some way. Another possibility is that the
alteration in the afferent limb is a consequence of
hemodynamic changes.
(3) Hernodynamic factors. It is probable that the
mesangium is influenced by the hemodynamic de-
terminants that affect glomerular filtration, although
very little information is currently available. The re-
cent demonstration of normal mesangial kinetics in
mercuric—chloride-induced renal failure in rats is
consistent with the normal GFR and RBF observed
in this model [80]. The increased macromolecular
uptake in bilateral ureteral obstruction compared
with the reduced uptake in unilateral obstruction is
largely unexplained, however [81].
Effereni meson gial limb
What happens to macromolecules after entry into
the mesangium? A number of routes of egress are
possible, including degradation by phagocytosis,
movement by way of the glomerular stalk to the jux-
taglomerular zone, and regurgitation into the gb-
merular capillary (Fig. 6).
(1) Phagocytosis. That the mesangial cell has the
capacity to phagocytose ferritin, thorotrast, and
gold was clearly demonstrated by the studies of
Farquhar and Palade [9] and Latta, Maunsbach, and
Madden [8]. The hypothesis was advanced that
macromolecules that become trapped along the
endothelial aspect of the peripheral GBM move into
the mesangium and are taken up by mesangial cells,
which police" the basement membrane and keep
the filter clean [9]. That the mesangial cell acts like a
component of the reticuloendothelial system was al-
so supported by the time course for uptake and dis-
appearance of AH lgG, which was similar to that
observed for liver and spleen [49]. In con-
tradistinction to certain tracers that were ac-
tively phagocytosed by mesangial cells, other ma-
terials, particularly antigen-antibody complexes
and aggregated proteins, were seen within mesan-
gial channels between cells and infrequently or not
at all within the cell itself. In addition, studies in
human and experimental forms of renal disease
have generally demonstrated deposits within the
mesangial matrix but not within glomerular cells.
The inability, however, to detect immune complex
material and aggregated proteins within mesangial
cells may be methodologic, and further morpholog-
ic data are needed to settle this issue definitively. Of
the macromolecules that move into and out of the
mesangial zone, it has not been possible to define
the relative proportion that undergoes phago-
cytosis. It is probable that uptake by the mesangium
does not depend on the mesangial cell acting like a
macrophage, actively engulfing macromolecules
from the glomerubar capillary lumen. Rather, it is
more likely that the mesangial cell has the capacity
to phagocytose certain materials that come close to it.
Monocytes have been demonstrated in diseased
glomeruli by morphologic and cultural techniques
[82—92]. Recent studies have emphasized the impor-
tance of these cells and cellular immune mecha-
nisms in the pathogenesis of both anti/GBM nephri-
tis and acute immune complex disease in animals
[88-90, 92]. The relationship between mesangial
cells and monocytes in the phagocytosis of immune
complexes was evaluated recently by an incisive
study carried out by Striker, Mannik, and Tung
[57]. By exchanging marrow between Chediak-Hi-
gashi mice and syngeneic mice after radiation, it
was possible to differentiate marrow-derived mac-
rophages, which contain giant lysosomes from resi-
dent mesangial cells. Following the systemic admin-
Phagocytosis
/ By mesangial cells
/ By infiltrating phagocytes
Circulating Afferent Efferent I
macromolecules —IMESANGIuMI tu'. Stalk—luxtaglomerular
transport
Capillary regurgitation
Fig. 6. Simplified schema depicting the macromolecular traffic into and out of the mesangiu,n. Capillary regurgitation of macromolecules
has not been definitively established.
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istration of immune complexes, phagocytosis could
be demonstrated only within marrow-derived
monocytes present within the mesangial region; no
phagocytosis could be demonstrated by mesangial
cells. Additional evidence that the mesangial cell
is not derived from an extrarenal cell population is
shown by the frequency of the Y-chromosome in
female human kidneys that had been transplanted
into a male host 1 month to 8 years previously [93].
Y-body-containing cells could be demonstrated in
the interstitium of the kidney and in glomerular
crescents, suggesting that inflammatory cells of the
male recipient populate these regions of the donated
female kidney. No Y-body containing cells, how-
ever, were present within the normal or prolifer-
ating mesangium, suggesting that mesangial cells
constitute a stable population and further that
phagocytic cells are not present in this site in these
transplanted kidneys. In analogous experimental
studies, kidneys from rats injected with Habu snake
venom were transplanted into recipients that had
been labeled previously with tritiated thymidine;
proliferating glomerular cells were not labeled, sug-
gesting local proliferation rather than population of
the mesangium by extrarenal cells [94].
Several conclusions may be derived from these
studies: (1) monocytic cells may infiltrate the gb-
merulus and in certain experimental situations enter
the mesangium and ingest immune complexes and
macromolecules; (2) there is no evidence that the
mesangial cell is derived from a mononuclear
phagocytic bone marrow cell similar to that de-
scribed for the pulmonary macrophage; (3) phago-
cytosis by mesangial cells has been observed by us-
ing certain probes such as ferritin and dextran,
whereas clear evidence for uptake of aggregated
proteins or immune complexes as a major pathway
for disposal has not been demonstrated. It is also
possible that degradation of mesangial complexes
may occur extracellularly following the excretion of
lysosomal enzymes and proteases.
(2) Transport via the stalk to the juxtaglomerular
zone. Immunofluorescent studies of the kidney fol-
lowing the administration of aggregated proteins to
animals often reveal significant amounts of material
at the axial pole of the glomerulus [48]. In addition,
iron dextran accumulates in the mesangium after
administration to mice; after a period of time it is
found in the region of the juxtaglomerular appa-
ratus, the intercellular spaces of the macula densa,
and the base of the distal tubular cells opposite the
maxula densa beneath the tubular basement mem-
brane [35]. In the rat, colloidal carbon gains access
to the mesangial channels by way of the endothelial
fenestra, and is maximally present in this site at 32
hours after administration, longer than that ob-
served for other probes [32]. During the subsequent
period of 2 months, the relative concentration of
carbon in the peripheral mesangium decreases asso-
ciated with a progressive increase in the stalk and
lacis regions. These morphologic studies are consis-
tent with the viewpoint that certain macromolecules
move from the peripheral mesangium to the gb-
merular stalk and thence to the juxtaglomerular re-
gion [8, 12, 95]. Although attractive because of the
anatomic relationship to the distal tubule, there is
no evidence for active secretion into the urine at
this site. Movement of macromolecules into this re-
gion, however, may permit entry into distal tubular
cells, the interstitial space, or the lymphatics. The
route of exit, however, has not been established at
this time.
(3) Other mechanisms. In addition to phago-
cytosis and transit by way of the stalk to the jux-
taglomerular zone, it is possible that regurgitation
from the mesangium into the glomerular capillary
might occur, although there are no morphologic
studies to support this hypothesis. This would sug-
gest that a dynamic equilibrium exists between
macromolecules present within the circulation and
those sequestered in the mesangium; pressure and
flow relationships would permit entry into the mes-
angium in one region and exit in another. Thus, at
high blood levels of the circulating macromolecule,
entrapment within the mesangium occurs during the
percolation of plasma through this site. As the
plasma level decreases, a new equilibrium is estab-
lished by movement of material out of the mesangial
zone.
Ureteral ligation altered mesangial kinetics in a
unique way, illustrating the importance of hemo-
dynamic factors in the regulation of mesangial traf-
fic of macromolecules [81] (Fig. 7): (1) A significant
difference in the afferent limb was observed be-
tween bilateral and unilateral obstruction, with a
higher uptake of AH IgG than normal in the former
and a lower uptake in the latter; the reason for this
difference is unknown and cannot be explained on
the basis of differences in blood flow or GFR. (2)
A plateau in glomerular concentration of AH IgG
was observed between 4 and 16 hours in obstructed
kidneys (efferent limb blockade), whereas in the
control or unobstructed kidney there was a signifi-
cant loss of AH IgG from the mesangium. During
this 4- to 16-hour period, the concentration in the
blood was relatively high. In the period of time after
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Fig. 7. Concentration of AH JgG in glorneruli at varying time
intervals after administration of AH igG to rats with bilateral
ureteral obstruction, unilateral obstruction, and controls. The
plot is as described in Fig. 3. Kinetic analysis for kidneys from
control animals is the same as it is for the contralateral normal
kidney from rats with unilateral obstruction and is here depicted
as a single line. Blood levels in all groups of animals were similar.
Note the difference in uptake between bilaterally obstructed and
unilaterally obstructed kidneys. In addition, the lack of a de-
crease in glomerular concentration of AH IgG between 4 and 16
hours in obstructed kidneys suggests efferent mesangial block-
ade. (Data derived from Ref. 81)
16 hours, however, a decrease in mesangial concen-
tration did occur, even with persistent ureteral ob-
struction, but associated with blood levels that were
less than 5% of initial values. These findings suggest
at least two mechanisms for movement of macro-
molecules out the mesangium—one which is im-
paired by ureteral obstruction and is manifested at
high circulating levels of the macromolecule, and
the other which is independent of ureteral obstruc-
tion and is operative at low circulating levels of
macromolecules. Whether the former represents
traffic through the stalk and juxtaglomerular region
and the latter represents regurgitation into the gb-
merular capillary remains to be proven.
That injury to the glomerulus might impair mac-
romolecular traffic through the mesangium is sug-
gested by studies on rats with long-standing ne-
phrotic syndrome and focal sclerosis induced by re-
peated injections of aminonucleoside of puromycin
[96, 97]. AH IgG administered to these animals per-
sists for prolonged periods of time within glomeruli,
suggesting that mesangial clearing mechanisms are
impaired as a consequence of the hyalinizing pro-
cess. The presence of immunoproteins in areas of
glomerular sclerosis in nonimmune forms of human
renal disease may reflect a similar impedence in the
traffic of endogenous complex material through the
mesangium [98]. In addition, following their ad-
ministration to rats, indigestible polyvinyl alcohol
polymers persist for prolonged periods of time in
the mesangium, inducing a remarkable ballooning
deposit and altering the mesangial uptake and dis-
appearance of AH IgG [39, 40].
Mesangialantigens
Myosin has been identified within the mesangium
by immunohistochemical techniques [13—15]. The
close proximity to components of the juxtaglomerular
apparatus supports the hypothesis that the mesangium
may have a contractile function and play an impor-
tant role in regulation of glomerular blood flow. The
demonstration of projections of mesangial cell cyto-
plasm in peripheral subendothelial portions of the
glomerular capillary, especially in disease states, is
consistent with the concept that the cell may be ac-
tive and mobile. In addition, fibronectin or fibro-
blast surface antigen has also been detected within
the mesangium where its distribution appears to be
more extensive than that of actomyosin [15, 99].
This protein is a noncollagen glycoprotein, which is
present on the surface of cultured fibroblasts and is
a major component of connective tissue matrices,
reticulin, and certain basement membranes [99]. On
the basis of its binding to collagens, it has been pro-
posed that this glycoprotein may mediate attach-
ment of cells to extracellular matrix material [100].
A striking increase in fibronectin and actomyosin
has been observed in the mesangium in diabetic
nephropathy [14, 15]. Neither antigen can be identi-
fied in hyalinized glomeruli. The cyclic nucleotide
3':5'-cyclic GMP has also been demonstrated in the
mesangium by immunohistochemical techniques
[101], and angiotensin II binds to a similar locus fol-
lowing its administration to rats [102]. As discussed
above, the biochemical composition of mesangial
matrix material is unknown, although immuno-
histochemical studies have demonstrated the pres-
ence of certain specific types of collagen, including
type IV procollagen and type V collagen, as well as
the noncollagen glycoproteins, fibronectin, and
laminin; these antigens are also present along the
subendothelial region of the GBM [103], Antibody
to enzyme-digested lung has been shown to react

















nature of the antigen(s) involved is unknown [104].
From the foregoing discussion, it is possible that
foreign antigens (for example, those of viral origin)
could move through the mesangium in vivo and be-
come trapped in this site, in a manner similar to that
described above. The demonstration in the mouse
that cytomegalovirus moves through mesangial
channels to the juxtaglomerular zone supports this
concept [105]. That a foreign antigen that has be-
come planted in the mesangium may set the stage
for the development of an in situ immune complex
disease has been demonstrated experimentally [46,
106]. For example, after AH IgG is administered to
a rabbit, the kidney containing mesangial aggre-
gates is transplanted to a normal animal, and anti-
IgG antibody is administered passively. The anti-
body, which reacts with the planted AH IgG, in-
duces an acute complement-dependent mesangitis
with polymorphonuclear infiltration. This study
demonstrates that foreign or possibly host antigens
that localize within the mesangium are not seques-
tered but are able to react with circulating antibody
and induce an intense mesangial inflammatory dis-
ease. This type of process, however, has not been
identified in human glomerulonephritis.
Conclusion
It is surprising how little we know about this
unique region of the glomerulus. It contains cells
with fibrils and myosin and an intercellular colla-
genous matrix material, situated adjacent to ele-
ments of the juxtaglomerular apparatus with which
an integrated functional relationship is likely, but
unproven. Studies of the mesangium in human dis-
ease have been limited to morphologic and immuno-
histologic studies. Abnormalities in this site have
been relatively specific in some diseases: the inter-
capillary nodule observed in diabetic nephropathy;
the mesangial ring of C3 outlining dense deposit ma-
terial in type II membranoproliferative glomerulo-
nephritis [107]; and the presence of IgA, C3, and
properdin without earlier complement components
in IgA nephropathy. Other mesangial abnormal-
ities—Ig and complement component deposition,
cellular proliferation, matrix expansion, sclerosis—
are not characteristic of any specific disease pro-
cess.
Studies in animals have begun to untangle some
of the complexities involved in the movement of
macromolecules into and out of the mesangium. UI-
trastructural studies that use a variety of probes
support the concept of plasmic flow through this re-
gion. The afferent pathway is influenced by a num-
ber of variables, including the blood level and, char-
acteristic of the macromolecule, the glomerular
blood flow, and likely other hemodynamic determi-
nants of glomerular filtration and unknown factors
that encourage movement from the capillary lumen
into the mesangium. The efferent pathway includes
transit by way of the glomerular stalk to the jux-
taglomerular zone, but thereafter the route is ob-
scure; phagocytosis by infiltrating cells or resident
mesangial cells; and possibly regurgitation into the
glomerular capillary at low blood levels of the circu-
lating macromolecule. Increased uptake has been
demonstrated in rats given aminonucleoside of pu-
romycin or anti-GBM antibody without alteration in
the efferent limb. In contrast, ureteral obstruction
induces efferent blockade.
The information accumulated in the recent past
by studies of the structure and function of the gb-
merular mesangium in laboratory animals demon-
strates a number of potential mechanisms to explain
some aspects of human glomerular disease. It
seems likely that additional understanding of these
concepts will lead to improved therapeutic ap-
proaches, as well as control and prevention of sev-
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